Microsoft OneNote doesn’t need any introduction. It has been the default choice for millions, a powerful workhorse for capturing everything from meeting notes to late-night ideas. Yet, the price of ...

SYNC-T demonstrated high efficacy in resolving bone metastases in metastatic prostate cancer, achieving an 87% overall response rate in a phase 1 trial. The therapy involves a minimally-invasive ...